PHOENIX, AZ – December 11, 2025 – PRESSADVANTAGE – Phoenix NP announced a continued rise in patient satisfaction across Arizona, noting that positive feedback has increased as more women seek safe, ...

The clinical trial showed this experimental medication to be much more effective than any existing GLP-1 drug. But that much ...

With foodborne illnesses and changes in Medicare and Medicaid coverage, University of Virginia (UVA) Health experts say never ...

Experts convened in Cleveland, Ohio, on November 11, 2025, to discuss the evolution of cardio-renal-metabolic care from ...

Important state and national stories, market and business news, sports and entertainment, delivered in quick-hit fashion ...

The pharmaceutical giant Eli Lilly has once again raised the bar in the highly competitive obesity treatment market. New clinical trial data for its experime ...

When the sensors and AI were helping, the participants could "very reliably" grasp a cup and pretend to take a sip, Trout ...

Retatrutide is an investigational triple agonist developed by Eli Lilly that targets GLP-1, GIP and glucagon receptors, and early trials suggest very strong ...

The company also said earlier this week it will drop $6 billion on a new manufacturing facility in Huntsville, Alabama.

As guys who value our health, and like the millions of Americans who voted for Donald Trump because he promised to help Make ...

Donald Trump slammed Kamala Harris as a socialist on the campaign trail, writes Bruce Fein, but his nationalization of U.S.

A proposed new federal law could provide some competitive guardrails for the company's most important product.